Ryuji Morizane, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Organoids | 22 | 2024 | 743 | 5.350 |
Why?
|
| Pluripotent Stem Cells | 15 | 2023 | 799 | 4.210 |
Why?
|
| Kidney | 24 | 2024 | 7047 | 2.860 |
Why?
|
| Nephrons | 6 | 2023 | 168 | 1.900 |
Why?
|
| Kidney Tubules | 6 | 2023 | 449 | 1.430 |
Why?
|
| Renal Insufficiency, Chronic | 5 | 2023 | 2243 | 0.950 |
Why?
|
| Cryoprotective Agents | 1 | 2024 | 128 | 0.860 |
Why?
|
| Polycystic Kidney, Autosomal Recessive | 1 | 2022 | 31 | 0.830 |
Why?
|
| Cell Differentiation | 17 | 2024 | 11530 | 0.830 |
Why?
|
| Induced Pluripotent Stem Cells | 4 | 2022 | 1860 | 0.790 |
Why?
|
| Regenerative Medicine | 3 | 2020 | 306 | 0.750 |
Why?
|
| Epithelial-Mesenchymal Transition | 2 | 2015 | 738 | 0.680 |
Why?
|
| Cryopreservation | 1 | 2024 | 728 | 0.640 |
Why?
|
| High-Throughput Screening Assays | 1 | 2024 | 934 | 0.610 |
Why?
|
| Embryonic Stem Cells | 4 | 2015 | 1263 | 0.590 |
Why?
|
| Cell Culture Techniques | 5 | 2019 | 1667 | 0.590 |
Why?
|
| Polycystic Kidney, Autosomal Dominant | 1 | 2019 | 166 | 0.590 |
Why?
|
| Kidney Tubules, Proximal | 5 | 2022 | 383 | 0.530 |
Why?
|
| Cell Transdifferentiation | 1 | 2015 | 186 | 0.470 |
Why?
|
| Diabetic Angiopathies | 1 | 2019 | 803 | 0.450 |
Why?
|
| Tissue Engineering | 3 | 2021 | 1868 | 0.450 |
Why?
|
| Lab-On-A-Chip Devices | 3 | 2024 | 432 | 0.430 |
Why?
|
| Immune Complex Diseases | 1 | 2012 | 50 | 0.410 |
Why?
|
| Ureteral Obstruction | 1 | 2014 | 293 | 0.400 |
Why?
|
| Apolipoprotein A-II | 1 | 2011 | 41 | 0.380 |
Why?
|
| Models, Biological | 4 | 2019 | 9469 | 0.380 |
Why?
|
| Cisplatin | 3 | 2024 | 1652 | 0.370 |
Why?
|
| Freezing | 2 | 2024 | 311 | 0.360 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2024 | 4063 | 0.360 |
Why?
|
| Glomerulonephritis | 1 | 2012 | 331 | 0.350 |
Why?
|
| Antibodies, Antineutrophil Cytoplasmic | 1 | 2012 | 289 | 0.350 |
Why?
|
| MicroRNAs | 3 | 2015 | 3816 | 0.340 |
Why?
|
| Myocytes, Cardiac | 1 | 2019 | 1668 | 0.340 |
Why?
|
| Organogenesis | 2 | 2021 | 215 | 0.330 |
Why?
|
| Peroxidase | 1 | 2012 | 609 | 0.320 |
Why?
|
| Genome, Human | 2 | 2021 | 4425 | 0.320 |
Why?
|
| Kidney Diseases | 3 | 2019 | 2091 | 0.310 |
Why?
|
| Cell Lineage | 4 | 2020 | 2556 | 0.310 |
Why?
|
| Epithelial Cells | 5 | 2022 | 3677 | 0.310 |
Why?
|
| Cadherins | 1 | 2013 | 903 | 0.310 |
Why?
|
| POEMS Syndrome | 1 | 2008 | 12 | 0.310 |
Why?
|
| Mammals | 2 | 2023 | 1132 | 0.280 |
Why?
|
| DNA Repair | 3 | 2022 | 2046 | 0.270 |
Why?
|
| Kidney Transplantation | 1 | 2021 | 4235 | 0.260 |
Why?
|
| Animals | 21 | 2024 | 168467 | 0.240 |
Why?
|
| Ethylene Glycol | 1 | 2024 | 31 | 0.240 |
Why?
|
| Regeneration | 3 | 2023 | 1512 | 0.240 |
Why?
|
| Amyloidosis | 1 | 2011 | 817 | 0.230 |
Why?
|
| Vitrification | 1 | 2024 | 51 | 0.230 |
Why?
|
| Dimethyl Sulfoxide | 1 | 2024 | 251 | 0.220 |
Why?
|
| Adrenal Insufficiency | 1 | 2023 | 194 | 0.190 |
Why?
|
| Antibodies, Bispecific | 1 | 2023 | 196 | 0.180 |
Why?
|
| Drugs, Investigational | 1 | 2022 | 212 | 0.180 |
Why?
|
| Bioengineering | 1 | 2021 | 99 | 0.180 |
Why?
|
| Kidney Tubules, Collecting | 1 | 2020 | 162 | 0.170 |
Why?
|
| Humans | 35 | 2024 | 761572 | 0.170 |
Why?
|
| Cells | 1 | 2021 | 165 | 0.170 |
Why?
|
| Biomedical Engineering | 1 | 2021 | 288 | 0.170 |
Why?
|
| Organ Culture Techniques | 2 | 2019 | 794 | 0.170 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2024 | 1334 | 0.160 |
Why?
|
| Calcium Signaling | 1 | 2023 | 733 | 0.150 |
Why?
|
| Proteins | 1 | 2013 | 6032 | 0.150 |
Why?
|
| Ureter | 1 | 2020 | 368 | 0.150 |
Why?
|
| Mice | 12 | 2023 | 81533 | 0.150 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2021 | 793 | 0.140 |
Why?
|
| Transforming Growth Factor beta | 2 | 2015 | 1962 | 0.140 |
Why?
|
| Endothelial Cells | 2 | 2024 | 3548 | 0.130 |
Why?
|
| Podocytes | 1 | 2020 | 405 | 0.130 |
Why?
|
| Imides | 1 | 2015 | 15 | 0.130 |
Why?
|
| Meclizine | 1 | 2015 | 13 | 0.130 |
Why?
|
| Germ Layers | 1 | 2015 | 72 | 0.130 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2014 | 1651 | 0.120 |
Why?
|
| Ischemic Preconditioning | 1 | 2015 | 89 | 0.120 |
Why?
|
| Drug Discovery | 1 | 2022 | 1051 | 0.120 |
Why?
|
| Tissue Culture Techniques | 1 | 2015 | 290 | 0.120 |
Why?
|
| Fibrosis | 3 | 2019 | 2049 | 0.120 |
Why?
|
| Acute Kidney Injury | 3 | 2018 | 1924 | 0.120 |
Why?
|
| Protective Agents | 1 | 2015 | 150 | 0.120 |
Why?
|
| Cell Survival | 1 | 2024 | 5791 | 0.120 |
Why?
|
| Models, Animal | 1 | 2020 | 2112 | 0.110 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2018 | 478 | 0.110 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2014 | 92 | 0.110 |
Why?
|
| Collagen Type III | 1 | 2014 | 91 | 0.110 |
Why?
|
| Cell Line | 4 | 2015 | 15601 | 0.110 |
Why?
|
| Ribonuclease III | 1 | 2015 | 279 | 0.110 |
Why?
|
| Neovascularization, Physiologic | 1 | 2020 | 1349 | 0.110 |
Why?
|
| RNA Splicing | 1 | 2018 | 918 | 0.110 |
Why?
|
| Calcium | 2 | 2023 | 5722 | 0.110 |
Why?
|
| Plasmids | 1 | 2018 | 2269 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2018 | 988 | 0.100 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2015 | 384 | 0.100 |
Why?
|
| Drug Delivery Systems | 1 | 2024 | 2226 | 0.100 |
Why?
|
| Interleukin-1beta | 1 | 2018 | 999 | 0.100 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2013 | 271 | 0.100 |
Why?
|
| Laminin | 1 | 2013 | 408 | 0.100 |
Why?
|
| NIH 3T3 Cells | 1 | 2013 | 670 | 0.100 |
Why?
|
| Forecasting | 1 | 2020 | 2928 | 0.090 |
Why?
|
| Extracellular Space | 1 | 2013 | 563 | 0.090 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2014 | 461 | 0.090 |
Why?
|
| Fibroblasts | 2 | 2019 | 4141 | 0.090 |
Why?
|
| Collagen Type I | 1 | 2014 | 616 | 0.090 |
Why?
|
| Mesoderm | 1 | 2013 | 674 | 0.090 |
Why?
|
| Phenotype | 3 | 2019 | 16592 | 0.090 |
Why?
|
| Fibronectins | 1 | 2014 | 723 | 0.090 |
Why?
|
| Transfection | 2 | 2015 | 5774 | 0.090 |
Why?
|
| Proteoglycans | 1 | 2013 | 803 | 0.090 |
Why?
|
| Quinolines | 1 | 2015 | 764 | 0.090 |
Why?
|
| Glial Cell Line-Derived Neurotrophic Factor | 1 | 2009 | 66 | 0.080 |
Why?
|
| DNA Damage | 1 | 2019 | 2449 | 0.080 |
Why?
|
| Bone Morphogenetic Protein 7 | 1 | 2009 | 110 | 0.080 |
Why?
|
| Genetic Association Studies | 1 | 2019 | 2735 | 0.080 |
Why?
|
| RNA Interference | 2 | 2015 | 2832 | 0.080 |
Why?
|
| Calcium-Binding Proteins | 1 | 2014 | 1069 | 0.080 |
Why?
|
| Reperfusion Injury | 1 | 2015 | 1023 | 0.080 |
Why?
|
| Immunohistochemistry | 2 | 2013 | 11076 | 0.080 |
Why?
|
| Immunoelectrophoresis | 1 | 2008 | 94 | 0.080 |
Why?
|
| Organ Specificity | 1 | 2013 | 1968 | 0.080 |
Why?
|
| Activins | 1 | 2009 | 210 | 0.080 |
Why?
|
| Cell Proliferation | 3 | 2018 | 10448 | 0.070 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2011 | 699 | 0.070 |
Why?
|
| Drug Combinations | 1 | 2013 | 2048 | 0.070 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2015 | 3778 | 0.070 |
Why?
|
| Base Sequence | 1 | 2018 | 12441 | 0.070 |
Why?
|
| Polyneuropathies | 1 | 2008 | 137 | 0.070 |
Why?
|
| Actins | 1 | 2014 | 2050 | 0.070 |
Why?
|
| Cells, Cultured | 2 | 2019 | 18965 | 0.070 |
Why?
|
| Protein Structure, Tertiary | 1 | 2013 | 3792 | 0.070 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2018 | 3639 | 0.060 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2013 | 1935 | 0.060 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2011 | 1492 | 0.060 |
Why?
|
| Collagen | 1 | 2013 | 2638 | 0.060 |
Why?
|
| Transcription Factors | 3 | 2020 | 12129 | 0.060 |
Why?
|
| DNA | 1 | 2018 | 7213 | 0.060 |
Why?
|
| Receptors, Corticotropin | 1 | 2023 | 24 | 0.060 |
Why?
|
| RNA, Messenger | 1 | 2019 | 12794 | 0.060 |
Why?
|
| Genetic Variation | 1 | 2019 | 6567 | 0.050 |
Why?
|
| Cell Movement | 1 | 2015 | 5205 | 0.050 |
Why?
|
| 25-Hydroxyvitamin D3 1-alpha-Hydroxylase | 1 | 2023 | 58 | 0.050 |
Why?
|
| Fura-2 | 1 | 2023 | 107 | 0.050 |
Why?
|
| HLA-A2 Antigen | 1 | 2023 | 211 | 0.050 |
Why?
|
| Glycolysis | 2 | 2018 | 835 | 0.050 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 2023 | 618 | 0.050 |
Why?
|
| Ovarian Neoplasms | 1 | 2018 | 4878 | 0.050 |
Why?
|
| Membrane Proteins | 2 | 2018 | 7858 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2019 | 20099 | 0.050 |
Why?
|
| Nuclear Proteins | 1 | 2015 | 5799 | 0.050 |
Why?
|
| Diabetes Mellitus | 1 | 2019 | 5841 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2018 | 9280 | 0.040 |
Why?
|
| Biomedical Research | 1 | 2015 | 3429 | 0.040 |
Why?
|
| WT1 Proteins | 1 | 2020 | 184 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 1 | 2018 | 7407 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2015 | 9420 | 0.040 |
Why?
|
| Interleukin-1 Receptor-Associated Kinases | 1 | 2018 | 76 | 0.040 |
Why?
|
| Ion Channels | 1 | 2023 | 1040 | 0.040 |
Why?
|
| Biological Transport | 1 | 2022 | 2091 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2018 | 11742 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2012 | 12975 | 0.030 |
Why?
|
| Membrane Transport Proteins | 1 | 2022 | 1035 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2023 | 1844 | 0.030 |
Why?
|
| Parathyroid Hormone | 1 | 2023 | 1803 | 0.030 |
Why?
|
| Mice, Inbred ICR | 1 | 2016 | 364 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2013 | 9177 | 0.030 |
Why?
|
| Azepines | 1 | 2018 | 329 | 0.030 |
Why?
|
| Sodium Cyanide | 1 | 2015 | 9 | 0.030 |
Why?
|
| Biopsy | 1 | 2008 | 6766 | 0.030 |
Why?
|
| Goals | 1 | 2021 | 711 | 0.030 |
Why?
|
| LLC-PK1 Cells | 1 | 2015 | 125 | 0.030 |
Why?
|
| Carboplatin | 1 | 2018 | 794 | 0.030 |
Why?
|
| Thyroid Hormones | 1 | 2018 | 404 | 0.030 |
Why?
|
| Ethanolamines | 1 | 2015 | 153 | 0.030 |
Why?
|
| Cytochromes c | 1 | 2015 | 173 | 0.030 |
Why?
|
| Cell Respiration | 1 | 2015 | 201 | 0.030 |
Why?
|
| Cross Reactions | 1 | 2016 | 817 | 0.030 |
Why?
|
| Deoxyglucose | 1 | 2015 | 333 | 0.030 |
Why?
|
| Antibody Specificity | 1 | 2016 | 1060 | 0.030 |
Why?
|
| Sialoglycoproteins | 1 | 2015 | 315 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2019 | 2468 | 0.030 |
Why?
|
| Galactose | 1 | 2015 | 297 | 0.030 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2015 | 411 | 0.030 |
Why?
|
| Glucocorticoids | 1 | 2023 | 2161 | 0.030 |
Why?
|
| Foreskin | 1 | 2013 | 33 | 0.030 |
Why?
|
| Deoxycytidine | 1 | 2018 | 877 | 0.030 |
Why?
|
| Immunophenotyping | 1 | 2019 | 1869 | 0.030 |
Why?
|
| PAX2 Transcription Factor | 1 | 2013 | 86 | 0.030 |
Why?
|
| Triazoles | 1 | 2018 | 903 | 0.030 |
Why?
|
| Pyrazines | 1 | 2018 | 1201 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2015 | 802 | 0.030 |
Why?
|
| Stromal Cells | 1 | 2018 | 1330 | 0.030 |
Why?
|
| Disease Models, Animal | 3 | 2019 | 18253 | 0.020 |
Why?
|
| Homeostasis | 1 | 2023 | 3323 | 0.020 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2013 | 411 | 0.020 |
Why?
|
| Adult | 2 | 2021 | 221203 | 0.020 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2013 | 592 | 0.020 |
Why?
|
| DNA Replication | 1 | 2018 | 1418 | 0.020 |
Why?
|
| Male | 6 | 2019 | 360842 | 0.020 |
Why?
|
| Carbachol | 1 | 2011 | 223 | 0.020 |
Why?
|
| Cell Separation | 1 | 2016 | 1720 | 0.020 |
Why?
|
| Tretinoin | 1 | 2013 | 519 | 0.020 |
Why?
|
| Extracellular Matrix | 1 | 2018 | 1726 | 0.020 |
Why?
|
| Cell Shape | 1 | 2011 | 371 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2018 | 3597 | 0.020 |
Why?
|
| Diphtheria Toxin | 1 | 2011 | 253 | 0.020 |
Why?
|
| Autophagy | 1 | 2018 | 1326 | 0.020 |
Why?
|
| N-Acetylglucosaminyltransferases | 1 | 2011 | 167 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 2019 | 2416 | 0.020 |
Why?
|
| Vitamin D | 1 | 2023 | 3303 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 2015 | 1989 | 0.020 |
Why?
|
| Aged | 2 | 2012 | 169310 | 0.020 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2011 | 504 | 0.020 |
Why?
|
| Pyrazoles | 1 | 2018 | 2009 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2016 | 4280 | 0.020 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2011 | 790 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2020 | 3801 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2015 | 4124 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2019 | 4415 | 0.020 |
Why?
|
| Swine | 1 | 2015 | 5915 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2018 | 4937 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 2015 | 22172 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 4575 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2019 | 14416 | 0.010 |
Why?
|
| Signal Transduction | 2 | 2018 | 23447 | 0.010 |
Why?
|
| Mitochondria | 1 | 2015 | 3624 | 0.010 |
Why?
|
| Female | 4 | 2019 | 392686 | 0.010 |
Why?
|
| Pyridines | 1 | 2013 | 2875 | 0.010 |
Why?
|
| Pyrimidines | 1 | 2013 | 3028 | 0.010 |
Why?
|
| Disease Progression | 1 | 2018 | 13510 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2008 | 36429 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2011 | 3612 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2011 | 5790 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2011 | 13446 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2011 | 10766 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2011 | 9541 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2011 | 17635 | 0.010 |
Why?
|
| Prognosis | 1 | 2018 | 29629 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2018 | 39107 | 0.010 |
Why?
|
| Genotype | 1 | 2011 | 12990 | 0.010 |
Why?
|
| Inflammation | 1 | 2015 | 10773 | 0.010 |
Why?
|
| United States | 1 | 2021 | 72335 | 0.010 |
Why?
|
| Pregnancy | 1 | 2013 | 29876 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2013 | 13642 | 0.010 |
Why?
|